In the early and mid-1980s, scientists used phages to express recombinant proteins. The protein was retained inside the virions, so screening required growing viral plaques, creating a stamp of these ...
Gensaic enters into collaboration to develop phage-derived gene therapies for central nervous system
Gensaic to collaborate exclusively with Ovid Therapeutics to develop up to three genetic medicines for CNS indications using its proprietary phage-derived particle (PDP) platform; terms are currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results